Literature DB >> 8124820

Noninvasive quantitative evaluation of the morphology of the major pulmonary artery branches in cyanotic congenital heart disease. Angiocardiographic and echocardiographic correlative study.

S Hiraishi1, H Misawa, H Hirota, Y Agata, Y Horiguchi, N Fujino, L H Yi, K Yashiro, S Nakae, M Kawada.   

Abstract

BACKGROUND: Precise noninvasive evaluation of pulmonary artery (PA) morphology is extremely important for medical and surgical management of patients with cyanotic heart disease. In this study, the accuracy of two-dimensional echocardiography combined with color Doppler flow mapping to assess the size, stenosis, and atresia of the major PA branches was examined using a new parasternal approach. METHODS AND
RESULTS: With the use of right and left high parasternal windows, we visualized each of the major portions along the right (R-PA) and left (L-PA) pulmonary arteries in 45 of the 47 examinations (96%) in 38 patients with cyanotic heart disease. The patients were between 13 days and 20 years old (mean age, 2.9 years). The internal diameters of the major PA branches were measured at three points along the R-PA (the proximal, mid, and distal portions) and at the proximal and distal portions on the L-PA in systole by both two-dimensional echocardiography and angiography. In addition, the diameter of the stenosis in the PA branch was measured. These PA values as determined by two-dimensional echocardiography correlated well with those obtained by angiography (r = .95 to .97). By two-dimensional echocardiography with color Doppler flow mapping, 17 of 19 lesions with stenoses or atresia of the major PA branches were predicted as defined by angiography (sensitivity, 89.5%; specificity, 100%). Differences between the distal parts of the L-PA and R-PA of > 30% in diameter were determined by angiography in 15 examinations and by two-dimensional echocardiography in 12 examinations (sensitivity, 80%; specificity, 97.4%).
CONCLUSIONS: Our technique permits noninvasive evaluation of the size, stenoses, and atresia of the major portions of the PA branches in patients with cyanotic heart disease both before and after surgery.

Entities:  

Mesh:

Year:  1994        PMID: 8124820     DOI: 10.1161/01.cir.89.3.1306

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Noninvasive assessment of elevated pulmonary vascular resistance in children with pulmonary hypertension secondary to congenital heart disease: A comparative study between five different Doppler indices.

Authors:  Alaa Mahmoud Roushdy; Iman Ragab; Wessam Abd El Raouf
Journal:  J Saudi Heart Assoc       Date:  2012-06-04

2.  Usefulness of electrocardiography-gated dual-source computed tomography for evaluating morphological features of the ventricles in children with complex congenital heart defects.

Authors:  Motoo Nakagawa; Masaki Hara; Keita Sakurai; Kazuya Ohashi; Miki Asano; Yuta Shibamoto
Journal:  Jpn J Radiol       Date:  2011-09-17       Impact factor: 2.374

3.  Quantitative assessment of pulmonary vascular resistance and reactivity in children with pulmonary hypertension due to congenital heart disease using a noninvasive method: new Doppler-derived indexes.

Authors:  Yayaoi Nakahata; Satoshi Hiraishi; Natsuko Oowada; Hisashi Ando; Sumito Kimura; Shinsuke Furukawa; Shohei Ogata; Masahiro Ishii
Journal:  Pediatr Cardiol       Date:  2008-10-28       Impact factor: 1.655

4.  Comparison of 16-multidetector-row computed tomography and angiocardiography for evaluating the central pulmonary artery diameter and pulmonary artery index in children with congenital heart disease.

Authors:  Motoo Nakagawa; Masaki Hara; Hidekazu Oshima; Yuta Shibamoto; Kantaro Mizuno; Miki Asano
Journal:  Radiat Med       Date:  2008-08-03

5.  Comparison of contrast enhanced magnetic resonance angiography with invasive cardiac catheterization for evaluation of children with pulmonary atresia.

Authors:  Soha Romeih; Fathia Al-Sheshtawy; Mai Salama; Nico A Blom; Ahmed Abdel-Razek; Hala Al-Marsafawy; Abdou Elhendy
Journal:  Heart Int       Date:  2012-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.